Literature DB >> 24818815

Adverse event reporting in the recent study by Imanaka et al. describing the efficacy and safety of tapentadol extended release for tumor-related pain.

Keiichiro Imanaka1, Yushin Tominaga, Mila Etropolski, Ilse Van Hove, Masaki Ohsaka, Mikio Wanibe, Keiichiro Hirose, Taka Matsumura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24818815     DOI： 10.1185/03007995.2014.919909

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN： 0300-7995            Impact factor:   2.580


× No keyword cloud information.
  1 in total

Review 1.  Oral tapentadol for cancer pain.

Authors:  Philip J Wiffen; Sheena Derry; Katrien Naessens; Rae F Bell
Journal:  Cochrane Database Syst Rev       Date:  2015-09-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.